Table 1.
Author | Year | Intervention | n | Mean Follow-up | Rate of OA | Additional Notes |
---|---|---|---|---|---|---|
Araki et al. [74] | 2020 | Calcium phosphate | 19 | 131mo | 26 % | |
Takeuchi et al. [100] | 2018 | Calcium phosphate | 26 | 87mo | 4 % | |
Kito et al. [99] | 2018 | PMMA alone | 5 | 336mo | 40 % | OA defined as Kellgren-Lawrence (KL) grade 3 or greater |
van der Heijden et al. [98] | 2013 | PMMA±Bone graft | 53 | 86mo | 17 % | OA defined as KL 3 or greater |
von Steyern et al. [97] | 2007 | PMMA alone | 9 | 132mo | 11 % | Mean distance from cement to cartilage: 1 mm |
Wada et al. [101] | 2002 | PMMA alone | 15 | 46mo | 7 % | |
Wu et al. [102] | 2018 | Bone graft + PMMA | 27 | 33mo | 11 % | All were KL2 or less |
Benevenia et al. [103] | 2017 | Bone graft alone | 4 | 59mo | 0 % | |
Bone graft + PMMA | 17 | 6 % | ||||
PMMA alone | 22 | 32 % | ||||
Xu et al. [95] | 2013 | Bone graft + PMMA | 34 | 35mo | 29 % | Reported on patients with <10 mm remaining subchondral bone |
PMMA alone | 23 | 57 % | ||||
Suzuki et al. [76] | 2007 | PMMA±Bone graft | 12 | 57mo | 25 % | Not significant (p = 0.429) |
Bone graft alone | 18 | 38 % | ||||
Szalay et al. [90] | 2006 | Bone graft alone | 44 | 24mo | 14 % | No significant difference beyond 50 months |
PMMA alone | 36 | 8 % |